Preventing lung cancer by stopping smoking - 01/09/11
Address reprint requests to: Richard D. Hurt, MD Mayo Clinic 200 First Street SW Rochester, MN 55905Résumé |
Much progress has been made in recent years in treating tobacco dependence. The 2000 USPHS Guideline extends the understanding of effective treatments and encourages clinicians to be more diligent in recognizing tobacco users in the practice and more aggressive in treating every tobacco user. The guideline outlines the potential use of the five first-line medications (bupropion, nicotine patches, gum, nasal spray, and inhaler) and the two second-line medications (nortriptyline and clonidine). The use of these medications can be tailored to meet the patients needs and combinations of these medications can be used when appropriate. More intensive treatment, such as residential treatment, may be needed for more addicted smokers.
Le texte complet de cet article est disponible en PDF.Plan
Vol 23 - N° 1
P. 27-36 - mars 2002 Retour au numéro
Article précédent
- Epidemiology, etiology, and prevention of lung cancer
- Kathryn Smith Bilello, Susan Murin, Richard A Matthay
- Lung cancer evolution to preinvasive management
- James L Mulshine, Frank Cuttitta, Melvyn S Tockman, Luigi M De Luca
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?